J Korean Ophthalmol Soc.  2024 Nov;65(11):745-748. 10.3341/jkos.2024.65.11.745.

Central Anticholinergic Syndrome Induced by Atropine Eye Drops: A Case Report

• Heo JS
• Lee JJ
• Choi SU
• Moon NJ
• Yeo JH

• KMID: 2560842
• DOI: http://doi.org/10.3341/jkos.2024.65.11.745

Abstract

Purpose
We present a case of central anticholinergic syndrome following the administration of atropine eye drops.
Case summary
A 60-year-old male presented with decreased visual acuity in his left eye and was diagnosed with intraocular lens dislocation. Preoperatively, Isopto atropine^® eye drops (1 drop at 15-minutes intervals) were used for pupil dilation. Within an hour of the first instillation, the patient exhibited drowsiness, disorientation, agitation, and urinary retention. Laboratory tests and computed tomography of the brain were unremarkable. Considering the recent administration of atropine eye drops, a diagnosis of central anticholinergic syndrome was made. The surgery was postponed and the patient recovered fully after 3 hours of observation. He remained asymptomatic during an additional day of hospitalization.
Conclusions
A small dose of atropine eye drops even at a therapeutic dose can induce central anticholinergic syndrome. Therefore, ophthalmologists should be aware of this rare and severe complication.

Keyword

Atropine, Central anticholinergic syndrome, Eye drops